MétaCan
Menu
Back to cohort
Record W3197326839 · doi:10.1093/eurheartj/ehab551

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society

2021· article· en· W3197326839 on OpenAlexafffund
Henry N. Ginsberg, Chris J. Packard, M. John Chapman, Jan Borén, Carlos A. Aguilar‐Salinas, Maurizio Averna, Brian A. Ference, Daniel Gaudet, Robert A. Hegele, Sander Kersten, Gary F. Lewis, Alice H. Lichtenstein, Philippe Moulin, Børge G. Nordestgaard, Alan T. Remaley, Bart Staels, Erik S.G. Stroes, Marja‐Riitta Taskinen, Lâle Tokgözoğlu, Anne Tybjærg‐Hansen, Jane K. Stock, Alberico L. Catapano

Bibliographic record

VenueEuropean Heart Journal · 2021
Typearticle
Languageen
FieldMedicine
TopicLipid metabolism and disorders
Canadian institutionsUniversité de MontréalWestern UniversityCégep de ChicoutimiUniversity of TorontoUniversité du Québec à Chicoutimi
FundersWageningen University and ResearchHLS TherapeuticsServierDaiichi-SankyoAmryt PharmaSilence TherapeuticsSanofiKowa CompanyMylanIonis PharmaceuticalsRegeneron PharmaceuticalsAmgenPfizerEuropean Atherosclerosis SocietyEli Lilly and CompanyAstraZenecaIronwood Pharmaceuticals, IncorporatedEsperion TherapeuticsGlaxoSmithKline
KeywordsMedicineLipoproteinMyocardial infarctionInternal medicineDiseaseAtherosclerotic cardiovascular diseaseCardiologyBioinformaticsEndocrinologyCholesterolBiology

Abstract

fetched live from OpenAlex

Recent advances in human genetics, together with a large body of epidemiologic, preclinical, and clinical trial results, provide strong support for a causal association between triglycerides (TG), TG-rich lipoproteins (TRL), and TRL remnants, and increased risk of myocardial infarction, ischaemic stroke, and aortic valve stenosis. These data also indicate that TRL and their remnants may contribute significantly to residual cardiovascular risk in patients on optimized low-density lipoprotein (LDL)-lowering therapy. This statement critically appraises current understanding of the structure, function, and metabolism of TRL, and their pathophysiological role in atherosclerotic cardiovascular disease (ASCVD). Key points are (i) a working definition of normo- and hypertriglyceridaemic states and their relation to risk of ASCVD, (ii) a conceptual framework for the generation of remnants due to dysregulation of TRL production, lipolysis, and remodelling, as well as clearance of remnant lipoproteins from the circulation, (iii) the pleiotropic proatherogenic actions of TRL and remnants at the arterial wall, (iv) challenges in defining, quantitating, and assessing the atherogenic properties of remnant particles, and (v) exploration of the relative atherogenicity of TRL and remnants compared to LDL. Assessment of these issues provides a foundation for evaluating approaches to effectively reduce levels of TRL and remnants by targeting either production, lipolysis, or hepatic clearance, or a combination of these mechanisms. This consensus statement updates current understanding in an integrated manner, thereby providing a platform for new therapeutic paradigms targeting TRL and their remnants, with the aim of reducing the risk of ASCVD.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.024
metaresearch head score (Gemma)0.013
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.024
Threshold uncertainty score0.127

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0240.013
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0040.002
Bibliometrics0.0020.002
Science and technology studies0.0020.005
Scholarly communication0.0070.007
Open science0.0040.006
Research integrity0.0140.021
Insufficient payload (model declined to judge)0.0020.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.033
GPT teacher head0.251
Teacher spread0.218 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations899
Published2021
Admission routes2
Has abstractyes

Explore more

Same venueEuropean Heart JournalSame topicLipid metabolism and disordersFrench-language works237,207